Market Expectations
Companies Health News

Dr. Reddy’s EBITDA Increases 119.1% YoY, PAT Up 18.2% YoY

Dr Reddy’s Laboratories on Wednesday announced its consolidated financial results for the quarter ended June 30, 2023. The company reported revenue growth of 29.1 per cent YoY and 7.0 per cent QoQ to Rs. 6,758 crores and above market expectations of Rs. 6,343 crores. The pharma major’s Profit after Tax stood at Rs. 1,405 crores, […]

Read More